
Sleep Aids in France
Description
Sleep Aids in France
Sales of sleep aids in France are experiencing double-digit volume and current value growth in 2024, despite the conclusion of the pandemic and its associated challenges. The rise in sales during the pandemic years of 2020-2021 was driven by heightened stress, anxiety, and insomnia, which resulted from lockdowns, remote working, home-schooling, and job security fears.
Euromonitor International's Sleep Aids in France report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. Forecasts to 2028 illustrate how the market is set to change.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Sleep Aids market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Table of Contents
24 Pages
- Sleep Aids in France
- Euromonitor International
- September 2024
- List Of Contents And Tables
- SLEEP AIDS IN FRANCE
- KEY DATA FINDINGS
- 2024 DEVELOPMENTS
- Sleep aids continues to reap benefits from consumer stress and anxiety
- Gummies gain rapid ground
- Sanofi’s Novanuit remains overall leader
- PROSPECTS AND OPPORTUNITIES
- Demand set to continue throughout forecast period, despite challenges ahead
- Possible new competition from other consumer health options
- Potential for expansion in sea magnesium, melatonin and CBD
- CATEGORY DATA
- Table 1 Sales of Sleep Aids: Value 2019-2024
- Table 2 Sales of Sleep Aids: % Value Growth 2019-2024
- Table 3 NBO Company Shares of Sleep Aids: % Value 2020-2024
- Table 4 LBN Brand Shares of Sleep Aids: % Value 2021-2024
- Table 5 Forecast Sales of Sleep Aids: Value 2024-2029
- Table 6 Forecast Sales of Sleep Aids: % Value Growth 2024-2029
- CONSUMER HEALTH IN FRANCE
- EXECUTIVE SUMMARY
- Consumer health in 2024: The big picture
- 2024 key trends
- Competitive landscape
- Retailing developments
- What next for consumer health?
- MARKET INDICATORS
- Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2019-2024
- Table 8 Life Expectancy at Birth 2019-2024
- MARKET DATA
- Table 9 Sales of Consumer Health by Category: Value 2019-2024
- Table 10 Sales of Consumer Health by Category: % Value Growth 2019-2024
- Table 11 NBO Company Shares of Consumer Health: % Value 2020-2024
- Table 12 LBN Brand Shares of Consumer Health: % Value 2021-2024
- Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2019-2024
- Table 14 Distribution of Consumer Health by Format: % Value 2019-2024
- Table 15 Distribution of Consumer Health by Format and Category: % Value 2024
- Table 16 Forecast Sales of Consumer Health by Category: Value 2024-2029
- Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2024-2029
- APPENDIX
- OTC registration and classification
- Vitamins and dietary supplements registration and classification
- Self-medication/self-care and preventive medicine
- Switches
- DISCLAIMER
- DEFINITIONS
- SOURCES
- Summary 1 Research Sources
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.